Skip to main content
Erschienen in: Journal of Neural Transmission 8/2013

01.08.2013 | Translational Neurosciences - Original Article

Association of VMAT2 gene polymorphisms with alcohol dependence

verfasst von: Christoph Fehr, Daniel Sommerlad, Thomas Sander, Ion Anghelescu, Norbert Dahmen, Armin Szegedi, Christiana Mueller, Peter Zill, Michael Soyka, Ulrich W. Preuss

Erschienen in: Journal of Neural Transmission | Ausgabe 8/2013

Einloggen, um Zugang zu erhalten

Abstract

Alcohol-related diseases cause significant harm in the western world. Up to 65 % of the phenotypic variance is genetically determined. Few candidate genes have been identified, comprising ADH4, ALDH2, COMT, CRHR1, DAT (SLC6A3), GABRA2 and MAOA. While abnormalities in the dopaminergic mesolimbic reward system are considered important mediators of alcoholism, studies analyzing variants of dopamine receptors showed conflicting results. Other modulators of the reward system are synaptosomal genes. Among candidate genes, polygenic variants of the Vesicular Monamine Transporter 2 (VMAT2) gene locus associated with alterations of drinking behavior were published. These variants comprise single nucleotide polymorphisms (SNPs) within the promoter region and the open reading frame. In this study, we confirm the association of VMAT2 SNP rs363387 (allelic association: p = 0.015) with alcohol dependence. This SNP defines several haplotypes including up to four SNPs (minimal p = 0.0045). In addition, numeric effects in the subgroups of males and patients with positive family history were found. We suggest that several rs363387 T-allele containing haplotypes increase the risk of alcohol dependence (OR 1.53), whereas G-allele containing haplotypes confer protection against alcohol dependence. Taken together, there is supporting evidence for a contribution of VMAT2 gene variants to phenotypes of alcohol dependence.
Literatur
Zurück zum Zitat APA (1994) Diagnostic and statistical manual of mental disorders, fourth edition (DSM IV). American Psychiatric Association, Washington APA (1994) Diagnostic and statistical manual of mental disorders, fourth edition (DSM IV). American Psychiatric Association, Washington
Zurück zum Zitat Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, Fisher S, Fox L, Howells W, Bertelsen S, Hinrichs AL, Almasy L, Breslau N, Culverhouse RC, Dick DM, Edenberg HJ, Foroud T, Grucza RA, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Krueger RF, Kuperman S, Lynskey M, Mann K, Neuman RJ, Nöthen MM, Nurnberger JIJR, Porjesz B, Ridinger M, Saccone NL, Saccone SF, Schuckit MA, Tischfield JA, Wang JC, Rietschel M, Goate AM, Rice JP, Gene, Environment Association Studies Consortium (2010) A genome-wide association study of alcohol dependence. Proc Natl Acad Sci USA 107:5082–5087CrossRefPubMed Bierut LJ, Agrawal A, Bucholz KK, Doheny KF, Laurie C, Pugh E, Fisher S, Fox L, Howells W, Bertelsen S, Hinrichs AL, Almasy L, Breslau N, Culverhouse RC, Dick DM, Edenberg HJ, Foroud T, Grucza RA, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Krueger RF, Kuperman S, Lynskey M, Mann K, Neuman RJ, Nöthen MM, Nurnberger JIJR, Porjesz B, Ridinger M, Saccone NL, Saccone SF, Schuckit MA, Tischfield JA, Wang JC, Rietschel M, Goate AM, Rice JP, Gene, Environment Association Studies Consortium (2010) A genome-wide association study of alcohol dependence. Proc Natl Acad Sci USA 107:5082–5087CrossRefPubMed
Zurück zum Zitat Bowirrat A, Oscar-Berman M (2005) Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 132B:29–37CrossRefPubMed Bowirrat A, Oscar-Berman M (2005) Relationship between dopaminergic neurotransmission, alcoholism, and reward deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 132B:29–37CrossRefPubMed
Zurück zum Zitat Dinwiddie SH, Reich T (1993) Genetic and family studies in psychiatric illness and alcohol and drug dependence. J Addict Dis 12:17–27CrossRefPubMed Dinwiddie SH, Reich T (1993) Genetic and family studies in psychiatric illness and alcohol and drug dependence. J Addict Dis 12:17–27CrossRefPubMed
Zurück zum Zitat Ducci F, Goldman D (2008) Genetic approaches to addiction: genes and alcohol. Addiction 103:1414–1428CrossRefPubMed Ducci F, Goldman D (2008) Genetic approaches to addiction: genes and alcohol. Addiction 103:1414–1428CrossRefPubMed
Zurück zum Zitat Erdfelder E, Faul F, Buchner A (1996) GPOWER: a general power analysis program. Behav Res Methods Instrum Comput 28:1–11CrossRef Erdfelder E, Faul F, Buchner A (1996) GPOWER: a general power analysis program. Behav Res Methods Instrum Comput 28:1–11CrossRef
Zurück zum Zitat Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166–5171CrossRefPubMed Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E (1996) Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA 93:5166–5171CrossRefPubMed
Zurück zum Zitat Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ (2002) Selected major risk factors and global and regional burden of disease. Lancet 360:1347–1360CrossRefPubMed Ezzati M, Lopez AD, Rodgers A, Vander Hoorn S, Murray CJ (2002) Selected major risk factors and global and regional burden of disease. Lancet 360:1347–1360CrossRefPubMed
Zurück zum Zitat Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271–1283CrossRefPubMed Fon EA, Pothos EN, Sun BC, Killeen N, Sulzer D, Edwards RH (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271–1283CrossRefPubMed
Zurück zum Zitat Gonzalez AM, Walther D, Pazos A, Uhl GR (1994) Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Brain Res Mol Brain Res 22:219–226CrossRefPubMed Gonzalez AM, Walther D, Pazos A, Uhl GR (1994) Synaptic vesicular monoamine transporter expression: distribution and pharmacologic profile. Brain Res Mol Brain Res 22:219–226CrossRefPubMed
Zurück zum Zitat Hack LM, Kalsi G, Aliev F, Kuo PH, Prescott CA, Patterson DG, Walsh D, Dick DM, Riley BP, Kendler KS (2011) Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish affected sib pair study of alcohol dependence (IASPSAD). Alcohol Clin Exp Res 35:376–385CrossRefPubMed Hack LM, Kalsi G, Aliev F, Kuo PH, Prescott CA, Patterson DG, Walsh D, Dick DM, Riley BP, Kendler KS (2011) Limited associations of dopamine system genes with alcohol dependence and related traits in the Irish affected sib pair study of alcohol dependence (IASPSAD). Alcohol Clin Exp Res 35:376–385CrossRefPubMed
Zurück zum Zitat Hall FS, Sora I, Uhl GR (2003) Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacology 28:620–628CrossRefPubMed Hall FS, Sora I, Uhl GR (2003) Sex-dependent modulation of ethanol consumption in vesicular monoamine transporter 2 (VMAT2) and dopamine transporter (DAT) knockout mice. Neuropsychopharmacology 28:620–628CrossRefPubMed
Zurück zum Zitat Harrington KA, Augood SJ, Kingsbury AE, Foster OJ, Emson PC (1996) Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson’s disease. Brain Res Mol Brain Res 36:157–162CrossRefPubMed Harrington KA, Augood SJ, Kingsbury AE, Foster OJ, Emson PC (1996) Dopamine transporter (Dat) and synaptic vesicle amine transporter (VMAT2) gene expression in the substantia nigra of control and Parkinson’s disease. Brain Res Mol Brain Res 36:157–162CrossRefPubMed
Zurück zum Zitat Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG (1997) Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 27:1381–1396CrossRefPubMed Heath AC, Bucholz KK, Madden PA, Dinwiddie SH, Slutske WS, Bierut LJ, Statham DJ, Dunne MP, Whitfield JB, Martin NG (1997) Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men. Psychol Med 27:1381–1396CrossRefPubMed
Zurück zum Zitat Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B (1994) Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J Exp Biol 196:251–262PubMed Henry JP, Botton D, Sagne C, Isambert MF, Desnos C, Blanchard V, Raisman-Vozari R, Krejci E, Massoulie J, Gasnier B (1994) Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules. J Exp Biol 196:251–262PubMed
Zurück zum Zitat Johnson RG Jr (1988) Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol Rev 68:232–307PubMed Johnson RG Jr (1988) Accumulation of biological amines into chromaffin granules: a model for hormone and neurotransmitter transport. Physiol Rev 68:232–307PubMed
Zurück zum Zitat Lin Z, Walther D, Yu XY, Li S, Drgon T, Uhl GR (2005) SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Hum Mol Genet 14:1393–1404CrossRefPubMed Lin Z, Walther D, Yu XY, Li S, Drgon T, Uhl GR (2005) SLC18A2 promoter haplotypes and identification of a novel protective factor against alcoholism. Hum Mol Genet 14:1393–1404CrossRefPubMed
Zurück zum Zitat Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539–551CrossRefPubMed Liu Y, Peter D, Roghani A, Schuldiner S, Prive GG, Eisenberg D, Brecha N, Edwards RH (1992) A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539–551CrossRefPubMed
Zurück zum Zitat Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143–149CrossRefPubMed Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143–149CrossRefPubMed
Zurück zum Zitat Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O’Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546–1552CrossRefPubMed Oslin DW, Berrettini W, Kranzler HR, Pettinati H, Gelernter J, Volpicelli JR, O’Brien CP (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28:1546–1552CrossRefPubMed
Zurück zum Zitat Pickel VM, Chan J, Nirenberg MJ (2002) Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 45:113–124CrossRefPubMed Pickel VM, Chan J, Nirenberg MJ (2002) Region-specific targeting of dopamine D2-receptors and somatodendritic vesicular monoamine transporter 2 (VMAT2) within ventral tegmental area subdivisions. Synapse 45:113–124CrossRefPubMed
Zurück zum Zitat Prescott CA, Kendler KS (2001) Associations between marital status and alcohol consumption in a longitudinal study of female twins. J Stud Alcohol 62:589–604PubMed Prescott CA, Kendler KS (2001) Associations between marital status and alcohol consumption in a longitudinal study of female twins. J Stud Alcohol 62:589–604PubMed
Zurück zum Zitat Savelieva KV, Caudle WM, Miller GW (2006) Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice. Alcohol 40:87–94CrossRefPubMed Savelieva KV, Caudle WM, Miller GW (2006) Altered ethanol-associated behaviors in vesicular monoamine transporter heterozygote knockout mice. Alcohol 40:87–94CrossRefPubMed
Zurück zum Zitat Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi A (2000) Reliability and validity of the German version of the European addiction severity index (EuropASI). J Stud Alcohol 61:916–919PubMed Scheurich A, Muller MJ, Wetzel H, Anghelescu I, Klawe C, Ruppe A, Lorch B, Himmerich H, Heidenreich M, Schmid G, Hautzinger M, Szegedi A (2000) Reliability and validity of the German version of the European addiction severity index (EuropASI). J Stud Alcohol 61:916–919PubMed
Zurück zum Zitat Schwab SG, Franke PE, Hoefgen B, Guttenthaler V, Lichtermann D, Trixler M, Knapp M, Maier W, Wildenauer DB (2005) Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence. Neuropsychopharmacology 30:2263–2268CrossRefPubMed Schwab SG, Franke PE, Hoefgen B, Guttenthaler V, Lichtermann D, Trixler M, Knapp M, Maier W, Wildenauer DB (2005) Association of DNA polymorphisms in the synaptic vesicular amine transporter gene (SLC18A2) with alcohol and nicotine dependence. Neuropsychopharmacology 30:2263–2268CrossRefPubMed
Zurück zum Zitat Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653–1658PubMed Selzer ML (1971) The Michigan alcoholism screening test: the quest for a new diagnostic instrument. Am J Psychiatry 127:1653–1658PubMed
Zurück zum Zitat Sigvardsson S, Bohman M, Cloninger CR (1996) Replication of the Stockholm adoption study of alcoholism. Confirmatory cross-fostering analysis. Arch Gen Psychiatry 53:681–687CrossRefPubMed Sigvardsson S, Bohman M, Cloninger CR (1996) Replication of the Stockholm adoption study of alcoholism. Confirmatory cross-fostering analysis. Arch Gen Psychiatry 53:681–687CrossRefPubMed
Zurück zum Zitat Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938–9943CrossRefPubMed Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938–9943CrossRefPubMed
Zurück zum Zitat Treutlein J, Rietschel M (2011) Genome-wide association studies of alcohol dependence and substance use disorders. Curr Psychiatry Rep 13:147–155CrossRefPubMed Treutlein J, Rietschel M (2011) Genome-wide association studies of alcohol dependence and substance use disorders. Curr Psychiatry Rep 13:147–155CrossRefPubMed
Zurück zum Zitat Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285–1296CrossRefPubMed Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG (1997) Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron 19:1285–1296CrossRefPubMed
Zurück zum Zitat WHO (2001) The world health report. Mental health: new understanding. New Hope, Geneve WHO (2001) The world health report. Mental health: new understanding. New Hope, Geneve
Zurück zum Zitat Wittchen HU, Lachner G, Wunderlich U, Pfister H (1998) Test-retest reliability of the computerized DSM-IV version of the Munich-composite international diagnostic interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568–578CrossRefPubMed Wittchen HU, Lachner G, Wunderlich U, Pfister H (1998) Test-retest reliability of the computerized DSM-IV version of the Munich-composite international diagnostic interview (M-CIDI). Soc Psychiatry Psychiatr Epidemiol 33:568–578CrossRefPubMed
Zurück zum Zitat Xu W, Emson PC (1997) Neuronal stem cells express vesicular monoamine transporter 2 immunoreactivity in the adult rat. Neuroscience 76:7–10CrossRefPubMed Xu W, Emson PC (1997) Neuronal stem cells express vesicular monoamine transporter 2 immunoreactivity in the adult rat. Neuroscience 76:7–10CrossRefPubMed
Metadaten
Titel
Association of VMAT2 gene polymorphisms with alcohol dependence
verfasst von
Christoph Fehr
Daniel Sommerlad
Thomas Sander
Ion Anghelescu
Norbert Dahmen
Armin Szegedi
Christiana Mueller
Peter Zill
Michael Soyka
Ulrich W. Preuss
Publikationsdatum
01.08.2013
Verlag
Springer Vienna
Erschienen in
Journal of Neural Transmission / Ausgabe 8/2013
Print ISSN: 0300-9564
Elektronische ISSN: 1435-1463
DOI
https://doi.org/10.1007/s00702-013-0996-y

Weitere Artikel der Ausgabe 8/2013

Journal of Neural Transmission 8/2013 Zur Ausgabe

Psychiatry and Preclinical Psychiatric Studies - Original Article

CID: a valid incentive delay paradigm for children

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Was nützt die Kraniektomie bei schwerer tiefer Hirnblutung?

17.05.2024 Hirnblutung Nachrichten

Eine Studie zum Nutzen der druckentlastenden Kraniektomie nach schwerer tiefer supratentorieller Hirnblutung deutet einen Nutzen der Operation an. Für überlebende Patienten ist das dennoch nur eine bedingt gute Nachricht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.